Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct;16(10):371-373.
doi: 10.5489/cuaj.7900.

Case - Orlistat-induced calcium oxalate crystalluria

Affiliations

Case - Orlistat-induced calcium oxalate crystalluria

Greta Handing et al. Can Urol Assoc J. 2022 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors do not report any competing personal or financial interests related to this work.

References

    1. Bhasin B, Ürekli HM, Atta MG. Primary and secondary hyperoxaluria: Understanding the enigma. World J Nephrol. 2015;4:235–44. doi: 10.5527/wjn.v4.i2.235. - DOI - PMC - PubMed
    1. Hoppe B, Langman CB. A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria. Ped Nephrol. 2003;18:986–91. doi: 10.1007/s00467-003-1234-x. - DOI - PubMed
    1. Buysschaert B, Aydin S, Morelle J, et al. Weight loss at a high cost: Orlistat-induced late-onset severe kidney disease. Diabetes Metab. 2016;42:62–4. doi: 10.1016/j.diabet.2015.08.006. - DOI - PubMed
    1. Chaudhari D, Crisostomo C, Ganote C, et al. Acute oxalate nephropathy associated with orlistat: A case report with a review of the literature. Case Rep Nephrol. 2013;2013:124604. doi: 10.1155/2013/124604. - DOI - PMC - PubMed
    1. Solomon LR, Nixon AC, Ogden L, et al. Orlistat-induced oxalate nephropathy: An under-recognized cause of chronic kidney disease. BMJ Case Rep. 2017;2017:bcr2016218623. doi: 10.1136/bcr-2016-218623. - DOI - PMC - PubMed

LinkOut - more resources